期刊文献+

PET/CT显像淋巴瘤病灶^(18)F-FDG摄取程度与肿瘤增殖性抗原Ki-67相关性研究 被引量:5

Study of the Correlation between ^(18)F-FDG Uptake Value of Lymphoma Lesion and Tumor's Proliferative Antigen Ki-67
下载PDF
导出
摘要 目的:通过对比50例不同病理亚型的淋巴瘤肿瘤增殖性抗原Ki-67表达水平与^(18)F-FDG PET显像病灶^(18)F-FDG浓聚程度来探讨两者之间相关性。方法:收集50例经病理及免疫组化证实的淋巴瘤病例,每个病例均有酶标肿瘤增殖性抗原Ki-67染色免疫组化报告,病理检查前或后常规行PET/CT检查。病理分型均采用WHO分类标准,并对非霍奇金淋巴瘤例按WF分类标准对其进行大小细胞类型归类。Ki-67酶标染色结果统一采用分级方法:核抗原染色阳性细胞百分数为0~5%,表示为微弱阳性(+/-);百分数为5%~20%,表示为弱阳性(+);百分数为20%~50%,表示为中阳性(++);百分数大于50%,表示为强阳性(+++)。PET/CT影像上,病灶^(18)F-FDG摄取程度采用半定量分析方法,计算出病灶平均标准化摄取值SUV(SU Vave)。利用统计软件(SPSS13.0)计算不同病理亚型的病灶^(18)F-FDG摄取值(以(?)±s表示),并对大、小细胞类型淋巴瘤的FDG摄取值差异显著性行t检验;对所有病灶Ki-67表达水平与^(18)F-FDG摄取程度两者之间采用Spearman方法进行相关性分析。结果:大细胞来源的淋巴瘤^(18)F-FDG摄取值远高于小细胞来源的淋巴瘤^(18)F-FDG摄取值,特别是B系大小细胞不同类型淋巴瘤,其^(18)F-FDG摄取值差异性更显著;Ki-67表达水平同结性与结外病灶^(18)F-FDG摄取值两者存在显著相关性,r值分别为0.750和0.843。结论:反映肿瘤增殖活性的Ki-67与淋巴瘤病灶^(18)F-FDG摄取程度有明显关系,Ki-67表达程度较高的大细胞性进展性淋巴瘤,其病灶^(18)F-FDG摄取值很高,而Ki-67表达程度较低的小细胞性低度恶性淋巴瘤,其^(18)F-FDG摄取值较低。 Purpose: To discuss the correlation between Ki- 67 level which represented tumor's prolif-eration antigen in immunohistochemical staining and the FDG uptake value in PET/CT imaging by comparing 50 cases of different subtypes of lymphomas.Methods: Fifty cases of lymphomas confirmed by pathology and immunohistochemistry were labeled Ki - 67 staining and performed PET/CT examination. All lymphoma cases were sorted according to the WHO classification,and NHL were divided into 2 groups (large cell group and small cell group) by using Working Formulation. The reports of Ki - 67 staining were described as follows: the expressed positive cell in nuclear antigen staining accounted for 0 - 5% as very weak ( + / - ) ; 5% - 20% as weak ( + ) ; 5% - 20% as moderate( + + ) ; 〉 50% as strong( + + + ). Semi - quantitative analysis was used to calculate the average standard uptake value(SUVave) of the FDG uptake of lesions in PET/CT imaging. And statistics software(SPSS13.0)was used as follow: the FDG uptake values of different subtype of lymphomas were described as ^-x ± s ; a student t test between the large cell lymphoma and small cell lymphoma was taken to prove the significant difference exist; and the correlation between the Ki - 67 level and FDG uptake of lesion was evaluated by Spearman analysis. Result: The FDG uptake values of large cell origin lymphomas were significant higher than that of small cell origin lymphoma, especially in B cell lymphoma; there was significant correlation between Ki - 67 level and FDG uptake value in lymph nodal or extranodal lesions. Conclusions: Ki - 67 which reflected tumor proliferative activity was clearly related to the FDG uptake value of lymphoma lesions. The large cell progressive lymphoma, which expressed high Ki - 67 level, resulted in intense FDG uptake; the small cell indolent lymphoma, which low expressed Ki- 67, the FDG uptake value decreased correspondingly.
出处 《中国医学计算机成像杂志》 CSCD 北大核心 2009年第3期278-284,共7页 Chinese Computed Medical Imaging
关键词 淋巴瘤 KI-67 ~18F-FDG PET/CT Lymphoma Ki - 67 ^18 F - FDG PET/CT
  • 相关文献

参考文献11

  • 1Jerusalem G, Hustinx R, Beguin Y, et al. Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 2005,17:441 - 445
  • 2Minn H, Joensuu H, Ahonene A, et al. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry on head and neck tumors. Cancer, 1988, 61: 1776- 1781
  • 3Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non - small cell lung cancer. J Nucl Med , 2000, 41:85 - 92
  • 4Buck AC, Schirrmeister HH, Guhlmann CA, et al. Ki - 67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med. 2001.42:721 - 725
  • 5Brown RS, Leung JY, Fisher SJ, et al. Intratumoral distribution of tritiated - FDG in breast carcinoma: Correlation between Glut - 1 expression and FDG uptake. J Nucl Med, 1996, 37:1042 - 1047
  • 6Hoffmann M, Raderer M. Malignant B - cell lymphoma, WHO classification and the respective ^18F- fluoro- deoxy - glucose positron emission tomography result. Imaging Decisions, 2006, 4: 14- 21
  • 7Kako S, Izutsu K, Ota Y, et al. FDG - PET in T - cell and NK - cell neoplasms. Ann Oncology, 2007,18: 1685- 1690
  • 8Bragg DG, Okuno W, Hricak H. Hodkin' s disease, lymphomas and the lymphoproliferative disorders//Bragg DG, Rubin P, Hricak H. Oncologic Imaging. 2rid ed. Philadelphia: WS Saunders, 2002: 855 - 883
  • 9Haberkorn U, Ziegler SI, Oberdorfer F, et al. FDG uptake, tumor proliferation and expression of glycolysis - associated genes in animal tumor models. Nucl Med Biol , 1994, 21:827- 834
  • 10Jaffe E S原著.周小鸽,陈辉树,主译.造血与淋巴组织肿瘤病理学和遗传学.北京:人民卫生出版社,2006:2-5

共引文献2

同被引文献32

  • 1于同刚,戴嘉中,冯晓源.原发性中枢神经系统淋巴瘤的MRI及^1H-MRS特点[J].临床放射学杂志,2005,24(8):668-672. 被引量:64
  • 2吴剑,杨湛.肿瘤浸润前沿细胞的生物学特性[J].医学综述,2007,13(13):986-988. 被引量:1
  • 3Gerstner ER,Batchelor TT.Primary central nervous system lymphoma[J].Arch Neurol,2010,67(3):291-297.
  • 4Schultz CJ,Bovi J.Current management of primary central nervous system lymphoma[J].Int J Radiat Oncol Biol Phys,2010,76(3):666-678.
  • 5Juweid M E,Cheson B D.Role of positron emission tomography in [ymphoma[J].J Clin 0ncol,2005,23(21):4577-4580.
  • 6Yi J H, Kim S J, Choi J Y, et al. 'SF-FDG Uptake and its Clinical Relevence in Primary Gastric Lymphoma[J].Hematol Oncol,2009, 10.
  • 7Radan L, Fischer D, Bar-Shalom R, et aI,FDG Avidity and PET-CT Patterns in Primary Gastric Lymphoma[J]. Eur J Nucl Med MolImaging,2008,35(8):1424-1430.
  • 8Mochiki E, Kuwano H, Katoh H, et al. Evaluation of 18F-2-de- oxy-2-fluoro-D-glucose Positron Emission Tomography for Gastric Cancer[J].World J Surg,2004,28(3):247-253.
  • 9Schocler H,Noy A,Gonen M,et al,lntensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive nonHodgkin's lymphoma[J]. J Clin On- col, 2005,23(21 )4643 -4651.
  • 10Ngeow J Y, Quek R H, Ng D C, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma [J]. Ann 0ncol,2009,20(9):1543-1547.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部